TWiV 1333: STING like a nanoparticle, float like HIV
TWiV explains research showing how HIV-1 signalling remodels nuclear pores to licence infection, and development of STING agonist nanoparticles to enable coordinated mucosal-systemic immunity for dura...
21 Kesä 1h 54min
TWiV 1332: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Daniel Griffin and Vincent Racaniello express concern about vaccine policy and ACIP, scaling back of the CDC's role in global public health, shingles vaccine and dement...
20 Kesä 54min
TWiV 1331: A drug for cervical cancer
TWiV explains research showing that dairy cows are infected with low doses of influenza A(H5N1) and do not transmit efficiently to other animals, and covalent inhibitors of human papillomavirus type 1...
14 Kesä 1h 58min
TWiV 1330: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Daniel Griffin and Vincent Racaniello opine on the recent executive order on the routine childhood vaccination schedule, the Ebola outbreak in the Congo and Uganda inclu...
13 Kesä 1h 11min
TWiV 1329: How HIV-1 goes nuclear
TWiV explains research showing limited transmission of cervid prions to nonhuman primates, and the finding that cone-shaped HIV-1 capsids are transported through intact nuclear pores. Hosts: Vincent R...
7 Kesä 1h 50min
TWiV 1328: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Daniel Griffin and Vincent Racaniello opine on the recent executive order on the routine childhood vaccination schedule, the Ebola outbreak in the Congo and Uganda inclu...
6 Kesä 1h
TWiV 1327: Influenza viruses in the MIST
TWiV explains research on human influenza virus transmission that reveals heterogeneous expulsion of infectious virus into air, and how gut bacteriophages dictate inflammation heterogeneity through tu...
31 Touko 1h 59min
